Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 56, Issue 17, Pages 6719-6731Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm400527k
Keywords
-
Categories
Funding
- Swiss National Science Foundation [PZ00P2_121989]
- Swiss Light Source
- Paul Scherrer Institute
- Swiss National Science Foundation (SNF) [PZ00P2_121989] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Carbon monoxide releasing molecules (CORMs) are an emerging class of pharmaceutical compounds currently evaluated in several preclinical disease models. There is general consensus that the therapeutic effects elicited by the molecules may be directly. ascribed to the biological function of the released CO. It remains unclear, however, if cellular internalization of CORMs is a critical event in their therapeutic action. To address the problem of cellular delivery, we have devised a general strategy which,entails conjugation of a CO-releasing molecule (here a photoactivated CORM) to the 5'-OH ribose group of vitamin B12. Cyanocobalamin (B12) functions as the biocompatible water-soluble scaffold which actively transports the CORM against a concentration gradient into the cells. The uptake and cellular distribution of this B-12-photoCORM conjugate is demonstrated via synchrotron FTIR spectromicroscopy. measuremente on living cells. Intracellular photoinduced CO release prevents fibroblasts from dying under conditions of hypoxia and metabolic depletion, conditions that may occur in vivo during insufficient blood supply to oxygen-sensitive tissues such as the heart or brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available